tiagabine has been researched along with Benign Psychomotor Epilepsy, Childhood in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Celani, MVB; Dos Santos, WF; Gobbo-Neto, L; Godoy, LD; Liberato, JL; Lopes, NP | 1 |
Morimoto, K; Sato, H; Suwaki, H; Watanabe, T; Yamamoto, Y | 1 |
Breustedt, J; Draguhn, A; Engel, D; Frahm, C; Heinemann, U; Numberger, M; Pfeiffer, M; Piechotta, A; Sabau, A | 1 |
Grabowska-Grzyb, A; WolaĆczyk, T | 1 |
Genton, P; Guerrini, R; Perucca, E | 1 |
Brouns, R; Van Paesschen, W | 1 |
1 review(s) available for tiagabine and Benign Psychomotor Epilepsy, Childhood
Article | Year |
---|---|
Tiagabine in clinical practice.
Topics: Anticonvulsants; Confusion; Drug Administration Schedule; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Humans; Nipecotic Acids; Practice Guidelines as Topic; Tiagabine; Treatment Outcome | 2001 |
5 other study(ies) available for tiagabine and Benign Psychomotor Epilepsy, Childhood
Article | Year |
---|---|
Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Male; Neurons; Neuroprotective Agents; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Pilocarpine; Rats, Wistar; Spider Venoms; Tiagabine; Urea | 2017 |
Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Dose-Response Relationship, Drug; Electric Stimulation; Electroencephalography; Epilepsy, Temporal Lobe; gamma-Aminobutyric Acid; Kindling, Neurologic; Male; Neurotransmitter Uptake Inhibitors; Nipecotic Acids; Picrotoxin; Rats; Rats, Sprague-Dawley; Tiagabine; Valproic Acid | 1997 |
Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
Topics: Action Potentials; Age Factors; Animals; Animals, Newborn; Anticonvulsants; Carrier Proteins; Entorhinal Cortex; Epilepsy, Temporal Lobe; Female; GABA Antagonists; GABA Plasma Membrane Transport Proteins; Hippocampus; Male; Membrane Proteins; Membrane Transport Proteins; Nipecotic Acids; Organic Anion Transporters; Rats; Rats, Wistar; Tiagabine | 1999 |
Transient dystonias in three patients treated with tiagabine.
Topics: Acute Disease; Adult; Anticonvulsants; Basal Ganglia Diseases; Carbamazepine; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystonia; Epilepsy; Epilepsy, Frontal Lobe; Epilepsy, Temporal Lobe; Female; Humans; Male; Nipecotic Acids; Tiagabine | 2001 |
Recurrent complex partial status epilepticus associated with tiagabine rechallenge.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Humans; Lorazepam; Male; Meningoencephalitis; Nipecotic Acids; Status Epilepticus; Tiagabine; Treatment Outcome | 2002 |